LifeMine Therapeutics
Develops fungal genome-derived therapeutics for organ transplant rejection
$263MSeries D+Series E
Role not disclosedActivity from announced rounds
Develops fungal genome-derived therapeutics for organ transplant rejection
Developing AI systems to discover and design new materials for clean energy and chipmaking
Builds quantum computers using lasers to hold individual atoms in place
AMI Labs develops world models that learn representations of sensor data to support prediction, memory and action planning.
Building a unified robotics foundation model for controlling robots